Abstract
The reaction of [ReOCl3(PPh3)2] with N-(2-hydroxybenzyl)-2-mercaptoaniline (H3hbma) (2) and 2-mercaptopyridine in hot CHCl yields [ReO(η2-HOC6H4-2-CH2NC6H4S)(η2-SC5H4N)(PPh3)] (3). The structure of 3 consists of distorted octahedral Re(V) monomers. The coordination geometry at the rhenium is defined by a terminal oxo-group, the nitrogen and sulfur donors of the chelating mercaptopyridine, the nitrogen and sulfur donors of a bidentate (Hhbma)2− ligand, and the phosphorus of the PPh3 group. The −C6H4OH arm of (Hhbma)2− is pendant, and the coordinated nitrogen of this ligand is present as a deprotonated amido nitrogen.
Keywords: Crystal structures, Rhenium complexes, Oxo complexes, Thiolate complexes
1. Introduction
The contemporary interest in the coordination chemistry of rhenium derives from the applications of the radioisotopes 186Re and 188Re to radiotherapy [1-5]. The discovery of novel radiopharmaceuticals is driven by synthesis of new materials. In this connection, one approach has focused on the robust {ReO}3+ core in combination with ligands possessing different donor sets and denticities. The most extensively developed strategy exploits ‘3+1’ ligand combinations, which contain a dianionic tridentate ligand with various donor atoms, but requiring at least one thiolate sulfur, and a monodentate thiol [6-9]. In addition, ‘2+2’ ligand combinations [10] and more recently ‘3+2’ chelates have been exploited [11,12].
In the course of our investigations of the coordination chemistry of the {ReO}3+ core with chelating ligands of varying denticity and different donor groups, several observations were made. Firstly, tridentate Schiff base ligands were effective for the expansion of the ‘3+1’ approach [13]. Secondly, dianionic tridentate ligands with alkoxo rather than thiol donors favored the isolation of ‘3+2’ chelate frameworks [12]. In an effort to conflate these two strategies, the chemistry of the ligand HOC6H4-2-CH2NHC6H4SH, N-(2-hydroxybenzyl)-2-mercaptoaniline (H3hbma) (2), the reduced form of the Schiff base N-(2-mercaptophenyl) salicylideneimine (1), with the {ReO}3+ core in the presence of the potentially bidentate ligand 2-mercaptopyridine was investigated. Two possible structural results were considered: (i) the H3hbma ligand would adopt a dianionic tridentate mode and the mercaptopyridine the common monodentate mode to provide a ‘3+1’ species with the conventional distorted square pyramidal geometry (A); (ii) the flexibility of the tridentate ligand together with the tendency of aryloxo and alkoxo ligands to occupy positions trans to the oxo-group would allow expansion of the coordination sphere to provide a ‘3+2’ complex (B). Curiously, neither expectation was realized, but rather the unusual six-coordinate ‘2+2+1’ complex [ReO(η2-HOC6H4-2-CH2NC6H4S)(η2-SC5H4N)(PPh3)] (3) was isolated.

2. Experimental
2.1. General considerations
NMR spectra were recorded on a Bruker DPX 300 (1H 300.10 MHz) spectrometer in CDCl3(δ 7.27 ppm). Elemental analysis for carbon, hydrogen and nitrogen were carried out by Oneida Research Services, Whites-boro, NY. Ammonium perrhenate, 2-mercaptopyridine, salicylaldehyde and 2-aminobenzenethiol were purchased from Aldrich and used without further purification. Reagent grade solvents, distilled and dried by standard methods, were used in all cases. Solutions were deaerated with 99.997% N2. [ReOCl3(PPh3)2] was prepared according to the literature [14]. Schiff base N-(2-mercaptophenyl)salicylideneimine (1) was prepared previously in this laboratory [13] and initially by Corbin and Work [15].
2.2. Preparation of ligand 2
The ligand 2 was prepared from the Schiff base N-(2-mercaptophenyl)salicylideneimine (1) by the method of Rajan [16] with minor modifications. The completeness of the reaction was monitored by the disappearance of C=N stretching band in the IR spectrum. The resulting thick, yellow, oily liquid was kept in a solution of CHCl3 and covered with N2. (yield: 35%). 1H NMR (CDCl3, ppm): 4.28 (s, 1H, SH); 4.44 (s, 2H, HOC6H4CH2 NH); 6.75–6.95 (m, 4H, ArH); 7.15–7.45 (m, 4H, ArH). Anal. Calc. for C13H13NOS: C, 67.53; H, 5.63; N, 6.06. Found: C, 68.01; H, 5.71; N, 5.96%.
2.3. Preparation of [ReO(η2-HOC6H4CH2NC6H4S) (η2-C5H4N-2-S)(PPh3)] (3)
To a solution of 23.1 mg (0.1 mmol) of 2 in dry, deaerated CHCl3 (20 cm3) was added ReOCl3(PPh3)2 (83 mg, 0.1 mmol) and subsequently 2-mercaptopyridine (12 mg, 0.11 mmol). The solution was heated to 60°C for 30 min. The resulting dark brown solution was evaporated to dryness under reduced pressure. The brown residue was dissolved in warm acetonitrile (10 cm3). Upon slow cooling, dark green-brown crystals were formed. (Yield: 38 mg, 45%). IR (KBr, cm−1): 1560(m), 1481(s), 1438(m), 1095(m), 920(m), 746(m).1H NMR (CDCl3, ppm): 2.00 (s, 3H, CH3 CN); 5.36 (d, J=6.7 Hz, 1H, HOC6H4CH2N eq); 5.95 (d, J=6.7 Hz, 1H, HOC6H4CH2N ax); 7.33 (s, 15H, PPh3); 6.7–7.7 (m, 12H, ArH). A few crystals were selected for X-ray analysis. Anal. Calc. for C36H30N2O2S2-PRe·CH3CN: C, 54.02; H, 3.91; N, 4.98. Found: C, 53.87; H, 3.97; N, 5.10%.
2.4. X-ray crystallography
Crystallographic data for 3 were collected with a Siemens P4 diffractometer equipped with the SMART CCD system [17] and using Mo Kα radiation (γ 0.71073 Å). The data were collected at 100 K. The data were corrected for Lorentz and polarization effects, and absorption corrections were made using SADABS [18]. The structure solution and refinement were carried out using the SHELXL-96 [19] software package. The structure was solved using direct methods and all of the non-hydrogen atoms were located from the initial solution. After locating all of the non-hydrogen atoms in each structure, the model was refined against F2, initially using isotropic and later anisotropic thermal displacement parameters until the final value of Δ/σmax was less than 0.001. At this point the hydrogen atoms were located from the electron density difference map and a final cycle of refinements was performed, until the final value of Δ/σmax was again less than 0.001. Crystallographic data are summarized in Table 1. Selected bond lengths and bond angles for 3 are given in Table 2.
Table 1.
Summary of crystallographic data of [ReO(η2-HOC6H4-2-CH2NC6H4S)(η2-SC5H4N)PPh3]·CH3CN (3·CH3CN)
| Empirical formula | C38H33N3O3PS2Re |
| Formula weight | 844.96 |
| Crystal system | monoclinic |
| Space group | P21/n |
| Unit cell dimensions | |
| a (Å) | 8.462(2) |
| b (Å) | 25.099(7) |
| c (Å) | 15.964(5) |
| β (°) | 90.208(7) |
| V (Å3) | 3390(2) |
| Z | 4 |
| Dcalc (g cm−3) | 1.655 |
| μ (cm−1) | 37.93 |
| R 1 a | 0.0456 |
| wR 2 b | 0.0736 |
R1 = Σ(Fo−Fc)/Σ(Fo).
.
Table 2.
Selected bond lengths (Å) and angles (°) for 3
| Bond lengths | |
| Re(1)–O(1) | 1.702(3) |
| Re(1)–N(1) | 1.993(5) |
| Re(1)–N(2) | 2.157(4) |
| Re(1)–S(1) | 2.3004(14) |
| Re(1)–S(2) | 2.5715(15) |
| O(2)–C(9) | 1.384(7) |
| S(1)–C(1) | 1.762(6) |
| S(2)–C(14) | 1.729(5) |
| N(1)–C(6) | 1.415(7) |
| N(1)–C(7) | 1.472(7) |
| N(2)–C(18) | 1.358(7) |
| N(2)–C(14) | 1.364(7) |
| Bond angles | |
| O(1)–Re(1)–N(1) | 105.79(17) |
| O(1)–Re(1)–N(2) | 87.70(17) |
| N(1)–Re(1)–N(2) | 91.29(17) |
| O(1)–Re(1)–S(1) | 107.32(13) |
| N(1)–Re(1)–S(1) | 82.37(13) |
| N(2)–Re(1)–S(1) | 164.77(12) |
| O(1)–Re(1)–P(1) | 90.70(13) |
| N(1)–Re(1)–P(1) | 163.51(13) |
| N(2)–Re(1)–P(1) | 89.36(12) |
| S(1)–Re(1)–P(1) | 92.85(5) |
| O(1)–Re(1)–S(2) | 148.49(12) |
| N(1)–Re(1)–S(2) | 88.85(13) |
| N(2)–Re(1)–S(2) | 63.77(12) |
| S(1)–Re(1)–S(2) | 102.11(5) |
| P(1)–Re(1)–S(2) | 76.67(5) |
| C(6)–N(1)–C(7) | 116.1(4) |
| C(6)–N(1)–Re(1) | 120.7(4) |
| C(7)–N(1)–Re(1) | 123.2(3) |
3. Discussion
The reaction of [ReOCl3(PPh3)2] with H3hbma and 2-mercaptopyridine in hot CHCl3 yields, after appropriate work-up, green-brown crystals of [ReO(η2-HOC6-H4-2-CH2NC6H4S)(η2-SC5H4N)(PPh3)]·CH3CN(3·CH3-CN) in 45% yield (Scheme 1). The observation of both the axial and equatorial protons of the –CH2– group in the 1H NMR spectrum at 5.95 and 5.36 ppm, respectively, confirms that the ligand has not been oxidized to the Schiff base. Furthermore, the absence of bands attributable to υ(N–H) in the infrared suggests that the nitrogen has been deprotonated in the course of the reaction. Finally, the presence of a resonance at 7.33 ppm in the 1H NMR spectrum, integrating to 15 protons, establishes that one PPh3 ligand remains coordinated to the rhenium.
Scheme 1.
As shown in Fig. 1, the structure of 3 consists of discrete mononuclear units with the Re(V) center in a distorted octahedral geometry. The coordination about the rhenium is defined by the terminal oxo-group, the nitrogen and sulfur donors of the dianionic (Hhbma)2− ligand, the nitrogen and sulfur donors of the 2-mercaptopyridine, and the phosphorus of the PPh3 ligand.
Fig. 1.
A view of the structure of 3, showing the atom-labeling scheme and 50% thermal ellipsoids.
Several features of the structure are noteworthy. The first is the retention of one PPh3 ligand. The common substitution pattern of the [ReOCl3(PPh3)2] precursor in the presence of chelating ligands results in loss of the sterically demanding PPh3 ligands. While stepwise substitution is relatively common, providing an intermediate which retains the {ReOCl2(PPh3)}+ core (Scheme 2) [20], addition of the second chelating ligand almost invariably results in displacement of the second PPh3 group. Related to this observation is the bidentate coordination mode of the (Hhbma)2− ligand. A triden-tate geometry with the phenoxy oxygen donor occupying the position trans to the oxo-group and concomitant loss of the PPh3 ligand (structure B) was the naive expectation. In fact, the hydroxyl group assumes a pendant role with the oxygen protonated. Consequently, the coordinated N1 nitrogen of the (Hhbma)2− ligand is deprotonated and binds as an amido ligand. The ability of transition metals in high oxidation states to deprotonate coordinated amino nitrogen ligands is well documented [16,21,22], and several examples of amido coordination to the {ReO}3+ core, subsequent to amino deprotonation, have been discussed [23,24]. The Re–N1 bond distance of 1.993(5) Å, compared to Re–N2 of 2.157(4) Å, the valence angles at N1 of 116.1(4), 120.7(4) and 123.2(3)° are consistent with an sp2 hybridized amido site.
Scheme 2.
Finally, it is curious that the chelating 2-mercaptopyridine is so disposed that the thiolate sulfur is trans to the terminal oxo-group. The π-donating thiolate ligand invariably occupies positions cis to the oxo-group, suggesting that the observed geometry is the consequence of steric constraints about the six-coordinate {Re(ON2S2P)} core of 3. The trans influence of the oxo-group is evident in the lengthening of the Re–S2 bond to 2.572(2) Å, compared to 2.300(1) Å for R–S1.
4. Conclusion
The reaction of [ReOCl3(PPh3)2] with the potentially bidentate 2-mercaptopyridine and the potentially tridentate N-(2-hydroxybenzyl)-2-mercaptoaniline (2) yields neither the ‘3+1’ nor the ‘3+2’ complex which was anticipated, but rather an unusual ‘2+2+1’ species with four different donor atoms about the Re(V) center to produce {Re(ON2S2P)} coordination geometry. The result not only illustrates the structural diversity of the {ReO}3+ core, but also reinforces observations that variable protonation sites and pendant groups can introduce significant structural complications in the design of radiopharmaceutical reagents.
Supplementary Material
Acknowledgements
This work was supported by a grant from the Department of Energy, Office of Health and Environmental Research (D2-FG02-99ER62791).
Footnotes
All atomic and thermal parameters and all inter-atomic angles are available from the authors upon request. Crystallographic data (excluding structure factor) for the structure reported in this paper have been deposited with the Cambridge Crystallographic Data Center as publication No. CCDC-139495. Copies of the data can be obtained free of charge from The Director, CCDC, 12 Union Road, Cambridge CB21EQ, UK (Fax: +44-1223-336-033; deposit@ccdc.cam.ac.uk or www: http//www.ccdc.cam.ac.uk).
References
- 1.Volkert W, Goeckeler WF, Ehrhardt GJ, Ketring AR. J. Nucl. Med. 1991;32:174. [PubMed] [Google Scholar]
- 2.DiZio JP, Fiaschi R, Davison A, Jones AG, Katzenellenbogen JA. Bioconjugate Chem. 1991;2:353. doi: 10.1021/bc00011a011. [DOI] [PubMed] [Google Scholar]
- 3.Deutsch EA, Libson K, Vanderheyden J-L. In: Technetium and Rhenium in Chemistry and Nuclear Medicine 3. Nicolini M, Bandoli G, Mazzi U, editors. Raven Press; New York: 1990. pp. 13–22. [Google Scholar]
- 4.Volkert WA, Hoffman TJ. Chem. Rev. 1999;99:2269. doi: 10.1021/cr9804386. [DOI] [PubMed] [Google Scholar]
- 5.Schubiger PA, Alberto R, Smith A. Bioconjugate Chem. 1996;7:165. doi: 10.1021/bc950097s. [DOI] [PubMed] [Google Scholar]
- 6.Pietzsch HJ, Spies H, Hoffman S, Stach J. Inorg. Chim. Acta. 1989;161:15. [Google Scholar]
- 7.Spies H, Fietz T, Pietzsch HJ, Johannsen B, Leibnitz P, Reck G, Scheller D, Klostermann K. J. Chem. Soc., Dalton Trans. 1995:2277. and references therein. [Google Scholar]
- 8.Papadopoulous M, Pirmettis I, Tsoukales C, Nock B, Maina T, Raptopolous CP, Pietzsch H-J, Friebe M, Spies H, Johannsen B, Chiotellis E. Inorg. Chim. Acta. 1999;295:1. [Google Scholar]
- 9.Maresca KP, Bonavia GH, Babich JW, Zubieta J. Inorg. Chim. Acta. 1999;284:252. and references therein. [Google Scholar]
- 10.Chi DY, Katzenellenbogen JA. J. Am. Chem. Soc. 1993;115:7045. [Google Scholar]
- 11.Nock B, Mania T, Tisato F, Papadopoulos M, Raptopoulou CP, Terzis A, Chiotellis E. Inorg. Chem. 1999;38:4197. doi: 10.1021/ic991341k. [DOI] [PubMed] [Google Scholar]
- 12.Femia FJ, Babich JW, Zubieta J. Inorg. Chim. Acta. 2000;300–302:462. doi: 10.1016/S0020-1693(99)00586-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Femia FJ, Chen X, Babich JW, Zubieta J. Inorg. Chim. Acta. 2000;300–302:517. doi: 10.1016/S0020-1693(99)00586-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Chatt J, Rowe GA. J. Chem. Soc. 1962:4019. [Google Scholar]
- 15.Corbin JL, Work DE. Can. J. Chem. 1974;52:1054. [Google Scholar]
- 16.Rajan QA, Spence JT, Leman C, Minelli M, Sato M, Enemark JH, Kroneck PMH, Sulger K. Inorg. Chem. 1983;22:3065. [Google Scholar]
- 17.Siemens . smart Software Reference Manual. Siemens Analytical X-ray Instruments; Madison, Wisconsin: 1994. [Google Scholar]
- 18.Sheldrick GM. sadabs: Program for Empirical Absorption Corrections. University of Gottingen; Germany: 1996. [Google Scholar]
- 19.Sheldrick GM. shelxl-96. Program for the Refinement of Crystal Structures. University of Gottingen; Germany: 1996. [Google Scholar]
- 20.Femia FJ, Chen X, Babich JW, Zubieta J. unpublished results. [Google Scholar]
- 21.Balch AL, Holm RH. J. Am. Chem. Soc. 1966;88:5201. [Google Scholar]
- 22.Stiefel EI, Waters JH, Billig E, Gray HB. J. Am. Chem. Soc. 1965;87:3016. [Google Scholar]
- 23.Hansen L, Lipowska M, Melendez E, Xu X, Hirota S, Taylor AT, Marzilli LG. Inorg. Chem. 1999;38:5351. doi: 10.1021/ic981151u. and references therein. [DOI] [PubMed] [Google Scholar]
- 24.Chi DY, Wilson SR, Katzenellenbogen JA. Inorg. Chem. 1995;34:1624. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



